These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. [The prospects for a study of meningococcal infection caused by serogroup B today]. Demina AA Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):111-7. PubMed ID: 3149839 [No Abstract] [Full Text] [Related]
49. Mucosal immunity and optimizing protection with meningococcal serogroup B vaccines. Heyderman RS; Davenport V; Williams NA Trends Microbiol; 2006 Mar; 14(3):120-4. PubMed ID: 16469496 [TBL] [Abstract][Full Text] [Related]
50. Lipoprotein NMB0928 from Neisseria meningitidis serogroup B as a novel vaccine candidate. Delgado M; Yero D; Niebla O; González S; Climent Y; Pérez Y; Cobas K; Caballero E; García D; Pajón R Vaccine; 2007 Dec; 25(50):8420-31. PubMed ID: 17996338 [TBL] [Abstract][Full Text] [Related]
51. [Anti-meningococcal vaccines]. Taha MK; Alonso JM Rev Prat; 2008 Dec; 58(19):2099-101. PubMed ID: 19213536 [TBL] [Abstract][Full Text] [Related]
52. Advances in the development of vaccines against Neisseria meningitidis. Tan LK; Carlone GM; Borrow R N Engl J Med; 2010 Apr; 362(16):1511-20. PubMed ID: 20410516 [No Abstract] [Full Text] [Related]
56. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. Holst J; Feiring B; Naess LM; Norheim G; Kristiansen P; Høiby EA; Bryn K; Oster P; Costantino P; Taha MK; Alonso JM; Caugant DA; Wedege E; Aaberge IS; Rappuoli R; Rosenqvist E Vaccine; 2005 Mar; 23(17-18):2202-5. PubMed ID: 15755595 [TBL] [Abstract][Full Text] [Related]
57. For discussion: live attenuated vaccines for group B meningococcus. Tang C; Moxon R; Levine MM Vaccine; 1999 Jan; 17(2):114-7. PubMed ID: 9987144 [TBL] [Abstract][Full Text] [Related]
58. New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months. Wong S; Lennon D; Jackson C; Stewart J; Reid S; Crengle S; Tilman S; Aaberge I; O'Hallahan J; Oster P; Mulholland K; Martin D Pediatr Infect Dis J; 2007 Apr; 26(4):345-50. PubMed ID: 17414400 [TBL] [Abstract][Full Text] [Related]
59. The meningococcal serogroup B vaccine protection trial in Norway 1988-1991: trial surveillance by an independent group. Halvorsen S NIPH Ann; 1991 Dec; 14(2):135-6; discussion 136-7. PubMed ID: 1812427 [No Abstract] [Full Text] [Related]
60. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain). Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA; Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]